These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37928219)

  • 1. A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms.
    Ciayadi TA; Palinrungi MA; Kholis K; Hendarto J; Syahrir S; Syarif S; Azis A
    Pan Afr Med J; 2023; 46():2. PubMed ID: 37928219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
    Sahin A; Yildirim C; Yuksel OH; Urkmez A
    Arch Esp Urol; 2020 Jan; 73(1):54-59. PubMed ID: 31950924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of stent related symptoms in patients taking mirabegron, solifenacin, or tamsulosin: A double blinded randomized clinical trial.
    Chandna A; Kumar S; Parmar KM; Sharma AP; Devana SK; Mete UK; Singh SK
    Urologia; 2022 Nov; 89(4):589-596. PubMed ID: 34596484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirabegron vs. solifenacin in control of endoscopically inserted ureteral stent-related symptoms.
    Abdelaziz AS; Salama NM; Ghoneem AM
    World J Urol; 2022 Aug; 40(8):2113-2119. PubMed ID: 35760910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.
    Ragab M; Soliman MG; Tawfik A; Abdel Raheem A; El-Tatawy H; Abo Farha M; Magdy M; Elashry O
    Int Urol Nephrol; 2017 Jun; 49(6):961-966. PubMed ID: 28260223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial.
    Park J; Yoo C; Han DH; Shin DW
    World J Urol; 2015 Nov; 33(11):1833-40. PubMed ID: 25809877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
    El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
    World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy.
    Lee YJ; Huang KH; Yang HJ; Chang HC; Chen J; Yang TK
    Urolithiasis; 2013 Jun; 41(3):247-52. PubMed ID: 23515684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms.
    Abdelhamid MH; Zayed AS; Ghoneima WE; Elmarakbi AA; El Sheemy MS; Aref A; Abdelbary A; Nour HH
    World J Urol; 2017 Aug; 35(8):1261-1268. PubMed ID: 28050642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
    Dellis AE; Papatsoris AG; Keeley FX; Bamias A; Deliveliotis C; Skolarikos AA
    J Endourol; 2017 Jan; 31(1):100-109. PubMed ID: 27809592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients.
    Robinson D; Kelleher C; Staskin D; Mueller ER; Falconer C; Wang J; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Hakimi Z; Herschorn S
    Neurourol Urodyn; 2018 Jan; 37(1):394-406. PubMed ID: 28704584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
    Chen YB; Gao L; Jiang Q; Ran K; Luo RT
    Curr Med Sci; 2019 Oct; 39(5):707-718. PubMed ID: 31612387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
    Wang J; Zhang X; Zhang T; Mu J; Bai B; Lei Y
    World J Urol; 2017 Nov; 35(11):1669-1680. PubMed ID: 28550362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial.
    Falahatkar S; Beigzadeh M; Mokhtari G; Esmaeili S; Kazemnezhad E; Amin A; Herfeh NR; Falahatkar R
    Int Braz J Urol; 2021; 47(3):596-609. PubMed ID: 33621009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirabegron for the Treatment of Ureteral Stent-related Symptoms: A Systematic Review and Meta-analysis.
    Van Besien J; Keller EX; Somani B; Pietropaolo A; Claessens M; Merckx L; Tailly T; De Coninck V
    Eur Urol Focus; 2022 Jul; 8(4):1031-1041. PubMed ID: 34688588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
    Jian Z; Chen Y; Liu Q; Liao B; Yang T; Li H; Wang K
    World J Urol; 2019 Feb; 37(2):289-297. PubMed ID: 30030658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Management of Ureteral Stent-related Symptoms: A Systematic Review, Bayesian Network Meta-analysis, and Meta-regression.
    Hinojosa-Gonzalez DE; Segall MR; Eisner BH
    J Urol; 2023 Nov; 210(5):739-749. PubMed ID: 37428119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study.
    Tang QL; Zhou S; Liu YQ; Wu J; Tao RZ
    Sci Rep; 2022 Nov; 12(1):18844. PubMed ID: 36344629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tadalafil add-on therapy in patients with persistant storage symptoms refractory to α
    Urakami S; Ogawa K; Oka S; Hagiwara K; Nagamoto S; Anjiki H; Hayashida M; Yano A; Sakaguchi K; Kurosawa K; Okaneya T
    Low Urin Tract Symptoms; 2019 May; 11(3):109-114. PubMed ID: 30251330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tamsulosin or mirabegron improve ureteral stent-related symptoms? A prospective placebo-controlled study.
    Yavuz A; Kilinc MF; Aydin M; Ofluoglu Y; Bayar G
    Low Urin Tract Symptoms; 2021 Jan; 13(1):17-21. PubMed ID: 32408390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.